Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,040 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 676-700 of 1,000 matching filings.

Per page
25
Current page
28
4

FORM 4 -

Filing date
04 Apr 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87213

SC 13D

Filing date
01 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
31 Mar 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
25 Mar 2016
Reporting date
23 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
25 Mar 2016
Reporting date
23 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Mar 2016
Reporting date
21 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Mar 2016
Reporting date
21 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Mar 2016
Reporting date
17 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Mar 2016
Reporting date
17 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87213

SC 13D/A

Filing date
16 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
15 Mar 2016
Reporting date
11 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
15 Mar 2016
Reporting date
11 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
07 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-209778

S-3

Filing date
26 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-209775

S-8

Filing date
26 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
25 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

OVAS SC13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

OVASCIENCE, INC.

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

ORBIS INVESTMENT MANAGEMENT LIMITED

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SCHEDULE 13G

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .